Global University Research Index

Medizinische Hochschule Hannover

Medizinische Hochschule Hannover longevity research profile: 2058 source-matched work links across 4 tracked topics, with transparent methodology and representative sources.

58.6Transparent research index score

2058Five-year longevity work links

4Longevity topics represented

25%Share indexed since 2025

100%Open-access representative sample

University website OpenAlex institution record ROR identity record

Hanover, Lower Saxony, Germany. This profile is generated from OpenAlex work affiliations resolved against ROR institution identities.

Topic profile

Where the indexed activity appears

Compare universities

Stem cells

1260 source-matched work links since 2022 · 376 since 2025 · 6767 citations across the representative sample

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms · 2022 · 4160 OpenAlex citations · open access
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · 2022 · 1499 OpenAlex citations · open access
Amyotrophic lateral sclerosis · 2022 · 1108 OpenAlex citations · open access

1260

Gene therapy

445 source-matched work links since 2022 · 0 since 2025 · 1108 citations across the representative sample

Amyotrophic lateral sclerosis · 2022 · 1108 OpenAlex citations · open access

445

Rapamycin

228 source-matched work links since 2022 · 88 since 2025 · 0 citations across the representative sample

No representative work was retained in the current sample.

228

Plasma exchange

125 source-matched work links since 2022 · 41 since 2025 · 1120 citations across the representative sample

Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis · 2023 · 327 OpenAlex citations · open access
Diagnosis and classification of optic neuritis · 2022 · 313 OpenAlex citations · open access
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management · 2023 · 252 OpenAlex citations · open access
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis · 2023 · 228 OpenAlex citations · open access

125